title: Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion.
authors: H
authors: H
authors: Narimatsu
authors: A
authors: A
authors: Wake
authors: Y
authors: Y
authors: Miura
authors: H
authors: H
authors: Tanaka
authors: T
authors: T
authors: Matsumura
authors: S
authors: S
authors: Takagi
authors: D
authors: D
authors: Kato
authors: T
authors: T
authors: Myojo
authors: E
authors: E
authors: Kusumi
authors: K
authors: K
authors: Masuoka
authors: S
authors: S
authors: Miyakoshi
authors: S
authors: S
authors: Morinaga
authors: H
authors: H
authors: Saji
authors: T
authors: T
authors: Ichinohe
authors: S
authors: S
authors: Taniguchi
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007518:Isoantibodies / Q000187:drug effects*; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D017713:Platelet Transfusion; D000069283:Rituximab; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D006680:HLA Antigens; D007518:Isoantibodies; D000069283:Rituximab